Research advances in the molecular mechanism of long non-coding RNA in invasion and metastasis of pancreatic cancer

Jian XU; Yanni PAN; Xinyuan LIU; Jianxin JIANG

doi:10.3969/j.issn.1001-5256.2022.01.043

Volume 38 Issue 1

Jan. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(1): 236-240

PDF( 2998 KB)

Research advances in the molecular mechanism of long non-coding RNA in invasion and metastasis of pancreatic cancer

DOI: 10.3969/j.issn.1001-5256.2022.01.043

Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan 430061, China

Research funding:

National Natural Science Foundation of China (81871965)

Received Date: 2021-05-27
Accepted Date: 2021-07-20
Published Date: 2022-01-20

Abstract

Abstract

As a highly malignant gastrointestinal tumor, pancreatic cancer is highly invasive and metastatic, which leads to the low overall survival rate of patients with pancreatic cancer. Studies have shown that long non-coding RNA (lncRNA) is involved in the development, progression, invasion, and metastasis of pancreatic cancer through epigenetic, transcriptional or post-transcriptional regulation. Dysregulated expression of lncRNA is observed in pancreatic cancer and induces epithelial mesenchymal transition (EMT) through specific regulatory mechanisms, thereby causing the changes in the biological behavior of tumor cells. This article reviews the mechanisms of lncRNA in promoting EMT, regulating tumor biological function as competing endogenous RNA, and affecting the development, invasion, and metastasis of pancreatic cancer via multiple pathways by regulating the ferroptosis, autophagy, and exosome of tumor cells, in order to provide a theoretical basis and new targets for the early diagnosis and treatment of pancreatic cancer.
- Pancreatic Neoplasms,
- RNA, Long Noncoding,
- Neoplasm Invasiveness,
- Neoplasm Metastasis

FullText(HTML)

References(44)

References

[1]	JIANG M, NI J, CUI W, et al. Emerging roles of lncRNA in cancer and therapeutic opportunities[J]. Cancers, 2019, 9(7): 1354-1366. DOI: 10.3390/cancers12123843.
[2]	DALGLEISH AG, STEBBING J, ADAMSON DJ, et al. Randomised, open-label, phase Ⅱ study of gemcitabine with and without IMM-101 for advanced pancreatic cancer[J]. Br J Cancer, 2016, 115(7): 789-796. DOI: 10.1038/bjc.2016.271.
[3]	WAN J. Research progress of exosomes long chain non-coding RNA in pathogenesis and molecular diagnosis of pancreatic cancer[J]. China Med Pharm, 2021, 11(3): 42-45. DOI: 10.3969/j.issn.2095-0616.2021.03.011. 万君. 外泌体长链非编码RNA在胰腺癌发病机制及分子诊断中的研究进展[J]. 中国医药科学, 2021, 11(3): 42-45. DOI: 10.3969/j.issn.2095-0616.2021.03.011.
[4]	XIE Y, ZHANG Y, DU L, et al. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer[J]. Mol Oncol, 2018, 12(5): 648-658. DOI: 10.1002/1878-0261.12188.
[5]	LIU H, HAN L, LIU Z, et al. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/ BRF2 pathway[J]. J Cell Physiol, 2019, 234(8): 13843-13850. DOI: 10.1002/jcp.28064.
[6]	BANFAI B, JIA H, KHATUN J, et al. Long noncoding RNAs are rarely translated in two human cell lines[J]. Genome Res, 2012, 22(9): 1646-1657. DOI: 10.1101/gr.134767.111.
[7]	TAHIRA AC, KUBRUSLY MS, FARIA MF, et al. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer[J]. Mol Cancer, 2011, 10: 141. DOI: 10.1186/1476-4598-10-141.
[8]	LIU M, YANG YT, XU G, et al. CCG: An integrative resource of cancer protein-coding genes and long noncoding RNAs[J]. Discov Med, 2016, 22(123): 351-359. https://pubmed.ncbi.nlm.nih.gov/28147217/
[9]	YOSHIDA K, TODEN S, RAVINDRANATHAN P, et al. Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression[J]. Carcinogenesis, 2017, 38(10): 1036-1046. DOI: 10.1093/carcin/bgx065.
[10]	CAI H, YAO J, AN Y, et al. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer[J]. Oncotarget, 2017, 8(20): 32905-32917. DOI: 10.18632/oncotarget.16462.
[11]	CHEN L, ZHANG J, CHEN Q, et al. Long noncoding RNA SOX2OT promotes the proliferation of pancreatic cancer by binding to FUS[J]. Int J Cancer, 2020, 147(1): 175-188. DOI: 10.1002/ijc.32827.
[12]	AIELLO NM, BRABLETZ T, KANG Y, et al. Upholding a role for EMT in pancreatic cancer metastasis[J]. Nature, 2017, 547(7661): E7-E8. DOI: 10.1038/nature22963.
[13]	XING SN, CHEN W, YU HY. Research status of mesenchymal stem cells on tumorigenesis and development[J]. Clin J Med Offic, 2020, 48(8): 980-982. DOI: 10.16680/j.1671-3826.2020.08.45. 邢思宁, 陈伟, 于卉影. 间充质干细胞对肿瘤发生发展影响研究现状[J]. 临床军医杂志, 2020, 48(8): 980-982. DOI: 10.16680/j.1671-3826.2020.08.45.
[14]	XU J, LIU S, YANG X, et al. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro[J]. Life Sci, 2020, 263: 118523. DOI: 10.1016/j.lfs.2020.118523.
[15]	TERASHIMA M, ISHIMURA A, WANNA-UDOM S, et al. MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells[J]. J Biol Chem, 2018, 293(47): 18016-18030. DOI: 10.1074/jbc.RA118.004006.
[16]	WU L, ZHU L, LI Y, et al. Correction to: LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis[J]. Cancer Cell Int, 2020, 20: 158. DOI: 10.1186/s12935-020-01239-2.
[17]	CHEN CW, FU M, DU ZH, et al. Long noncoding RNA MRPL23-AS1 promotes adenoid cystic carcinoma lung metastasis[J]. Cancer Res, 2020, 80(11): 2273-2285. DOI: 10.1158/0008-5472.CAN-19-0819.
[18]	SHEN J, HONG L, YU D, et al. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression[J]. Int J Biochem Cell Biol, 2019, 113: 17-26. DOI: 10.1016/j.biocel.2019.05.021.
[19]	GAO Y, ZHANG Z, LI K, et al. Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells[J]. Cell Death Dis, 2017, 8(7): e2924. DOI: 10.1038/cddis.2017.311.
[20]	ZHENG S, CHEN H, WANG Y, et al. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner[J]. Cancer Lett, 2016, 371(2): 354-365. DOI: 10.1016/j.canlet.2015.12.010.
[21]	WEI W, LIU Y, LU Y, et al. LncRNA XIST promotes pancreatic cancer proliferation through miR-133a/EGFR[J]. J Cell Biochem, 2017, 118(10): 3349-3358. DOI: 10.1002/jcb.25988.
[22]	GAO H, GONG N, MA Z, et al. LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis[J]. Int J Biol Macromol, 2018, 116(545-551). DOI: 10.1016/j.ijbiomac.2018.05.044.
[23]	LEI S, HE ZW, CHEN TX, et al. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway[J]. J Exp Clin Cancer Res, 2019, 38(1): 470. DOI: 10.1186/s13046-019-1388-4.
[24]	ZHANG H, ZHU CH, HE ZW, et al. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis[J]. J Exp Clin Cancer Res, 2020, 39(1): 179. DOI: 10.1186/s13046-020-01687-8.
[25]	ZHANG F, LI J, XIAO H, et al. AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers[J]. Cell Prolif, 2018, 51(1): e12397. DOI: 10.1111/cpr.12397.
[26]	WANG J, HE ZW, XU J, et al. Long noncoding RNA LINC00941 promotes pancreatic cancer progression by competitively binding miR-335-5p to regulate ROCK1-mediated LIMK1/Cofilin-1 signaling[J]. Cell Death Dis, 2021, 12(1): 36. DOI: 10.1038/s41419-020-03316-w.
[27]	XU J, WANG J, HE Z, et al. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer[J]. Cell Death Dis, 2021, 12(7): 648. DOI: 10.1038/s41419-021-03921-3.
[28]	MENG XP, MA J, WANG BS, et al. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway[J]. J Physiol Biochem, 2020, 76(2): 301-315. DOI: 10.1007/s13105-020-00734-4
[29]	GAI C, LIU C, WU X, et al. MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells[J]. Cell Death Dis, 2020, 11(9): 751. DOI: 10.1038/s41419-020-02939-3.
[30]	HIRSCHHORN T, STOCKWELL BR. The development of the concept of ferroptosis[J]. Free Radic Biol Med, 2019, 133: 130-143. DOI: 10.1016/j.freeradbiomed.2018.09.043.
[31]	PAN L, ZHOU L, YIN W, et al. miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission[J]. Int J Oncol, 2018, 53(1): 124-136. DOI: 10.3892/ijo.2018.4380.
[32]	HAYANO M, YANG WS, CORN CK, et al. Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation[J]. Cell Death Differ, 2016, 23(2): 270-278. DOI: 10.1038/cdd.2015.93.
[33]	ZHOU C, YI C, YI Y, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes[J]. Mol Cancer, 2020, 19(1): 118. DOI: 10.1186/s12943-020-01237-y.
[34]	LI L, CHEN H, GAO Y, et al. Long Noncoding RNA MALAT1 promotes aggressive pancreatic cancer proliferation and metastasis via the stimulation of autophagy[J]. Mol Cancer Ther, 2016, 15(9): 2232-2243. DOI: 10.1158/1535-7163.MCT-16-0008.
[35]	MAUSE SF, WEBER C. Microparticles: Protagonists of a novel communication network for intercellular information exchange[J]. Circ Res, 2010, 107(9): 1047-1057. DOI: 10.1161/CIRCRESAHA.110.226456.
[36]	MAIA J, CAJA S, STRANO MORAES MC, et al. Exosome-based cell-cell communication in the tumor microenvironment[J]. Front Cell Dev Biol, 2018, 6: 18. DOI: 10.3389/fcell.2018.00018.
[37]	LI Z, JIANG P, LI J, et al. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma[J]. Oncogene, 2018, 37(28): 3822-3838. DOI: 10.1038/s41388-018-0237-9.
[38]	ZHANG C, MENG D, ZHANG BY. The role of exocrine in the diagnosis of pancreatic cancer[J]. J Clin Hepatol, 2019, 35(5): 1165-1167. DOI: 10.3969/j.issn.1001-5256.2019.05.053. 张程, 孟迪, 张禀业. 外泌体在胰腺癌诊断中的作用[J]. 临床肝胆病杂志, 2019, 35(5): 1165-1167. DOI: 10.3969/j.issn.1001-5256.2019.05.053.
[39]	ZHANG H, SHI X, HUANG T, et al. Dynamic landscape and evolution of m6A methylation in human[J]. Nucleic Acids Res, 2020, 48(11): 6251-6264. DOI: 10.1093/nar/gkaa347.
[40]	LIU Z, ZHANG JZ. Most m6A RNA modifications in protein-coding regions are evolutionarily unconserved and likely nonfunctional[J]. Mol Biol Evol, 2018, 35(3): 666-675. DOI: 10.1093/molbev/msx320.
[41]	KONG F, LIU X, ZHOU Y, et al. Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells[J]. Int J Biochem Cell Biol, 2020, 122: 105731. DOI: 10.1016/j.biocel.2020.105731.
[42]	ZHAO Y. Effect of m6A demethylation ALKBH5 on malignant biological behavior of pancreatic cancer and its mechanism[D]. Wuhan: Huazhong University of Science and Technology, 2018. 赵炎. m6A去甲基化酶ALKBH5对胰腺癌恶性生物学行为的影响及机制的研究[D]. 武汉: 华中科技大学, 2018.
[43]	ZHANG C, ZHANG M, GE S, et al. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer[J]. Cancer Med, 2019, 8(10): 4766-4781. DOI: 10.1002/cam4.2360.
[44]	WU Y, YANG X, CHEN Z, et al. m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1[J]. Mol Cancer, 2019, 18(1): 87. DOI: 10.1186/s12943-019-1014-2.

Relative Articles

[1]	Ke SHI, Qun ZHANG, Xianbo WANG, Ying FENG. Effect of intestinal flora and metabolites on the development and progression of acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2025, 41(3): 568-573. doi: 10.12449/JCH250327
[2]	Viral Hepatitis Group of Professional Committee of Liver Disease （combined traditional Chinese and western medicine） of Chinese Research Hospital Association, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases. Guidelines for fecal microbiota transplantation therapy in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2025, 41(3): 424-431. doi: 10.12449/JCH250306
[3]	Xiaoming WU, Qiang HE, Linyi HOU, Yan HU, Xiaofang ZHEN, Jing HAO, Yan SHENG. Effect of Yudantong decoction on intestinal flora and intestinal barrier function in mice with cholestasis induced by α-naphthyl isothiocyanate[J]. Journal of Clinical Hepatology, 2023, 39(4): 864-875. doi: 10.3969/j.issn.1001-5256.2023.04.018
[4]	Hongkai XU, Chunfu WANG, Ye ZHANG, Jianqi LIAN. Role of fecal microbiota transplantation in chronic liver diseases[J]. Journal of Clinical Hepatology, 2023, 39(9): 2237-2243. doi: 10.3969/j.issn.1001-5256.2023.09.031
[5]	Guirong CHEN, Minggang WANG, Huaming LIN, Huiping YAN, Xiufeng WANG. Changes and pathogenic mechanism of intestinal flora in acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(8): 1992-1998. doi: 10.3969/j.issn.1001-5256.2023.08.034
[6]	Quan ZHOU, Chunlin CAI, Jinqiang LI. Gut-liver axis： Intestinal microbial homeostasis and hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(11): 2710-2717. doi: 10.3969/j.issn.1001-5256.2023.11.029
[7]	Yixin HOU, Qun ZHANG, Yuyong JIANG, Hao YU, Yuying YANG, Xianbo WANG. Effect of Liangxue Jiedu decoction on intestinal flora in patients with hepatitis B virus-related acute-on-chronic liver failure: An analysis based on high-throughput sequencing[J]. Journal of Clinical Hepatology, 2022, 38(6): 1280-1287. doi: 10.3969/j.issn.1001-5256.2022.06.013
[8]	Fuchun WANG, Ziyi LI, Wanjie ZHANG, Xiaorong MAO, Junfeng LI. The significance of gut microbiota in acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2022, 38(7): 1667-1670. doi: 10.3969/j.issn.1001-5256.2022.07.040
[9]	Transplantation Immunology Committee of Branch of Organ Transplantation Physician of Chinese Medical Doctor Association, Organ Transplant Rehabilitation Committee of China Association Rehabilitation Medicine, Branch of Organ Transplantation Physician of Guangdong Medical Doctor Association. Expert consensus on liver transplantation perioperative evaluation and rehabilitation for acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2022, 38(12): 2701-2708. doi: 10.3969/j.issn.1001-5256.2022.12.005
[10]	Hui DENG, Bin ZHANG, Bin ZHU, Zhayier DILIHUMAER, Weixian WANG, Chunxia GUO, Dongliang YANG, Xin ZHENG, Junzhong WANG, Baoju WANG. Research advances in the role of gut microbiota in chronic hepatitis B, chronic hepatitis C, and related liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(5): 1143-1147. doi: 10.3969/j.issn.1001-5256.2022.05.035
[11]	Mingyin MAN, Nana LI, Yue BU, Kaijiang YU. Influence of mitochondria-targeted antioxidant SS-31 on acute liver injury in a mouse model of sepsis[J]. Journal of Clinical Hepatology, 2022, 38(2): 392-396. doi: 10.3969/j.issn.1001-5256.2022.02.025
[12]	Xujuan LUO, Xue BAI, Zenghui LI, Fan LIU, Hao TANG, Ruoxin LI, Guodong YANG. Clinical effect of fecal microbiota transplantation versus the traditional Chinese medicine Rheum officinale in a rat model of hyperlipidemic acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(12): 2767-2773. doi: 10.3969/j.issn.1001-5256.2022.12.016
[13]	Ziwei GUO, Jiaxin ZHANG, Shuo LI, Xiaobin LI, Shun ZHU, Qian JIN, Xiaoke LI, Yongan YE. Research advances in intestinal flora and the development and prognosis of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2022, 38(5): 1137-1142. doi: 10.3969/j.issn.1001-5256.2022.05.034
[14]	Lingyan XIAO, Awen XING, Shanzhong TAN. Research advances in the association between liver failure and intestinal barrier injury[J]. Journal of Clinical Hepatology, 2021, 37(11): 2710-2714. doi: 10.3969/j.issn.1001-5256.2021.11.049
[15]	Yanyan CHEN, Yanmei LAN, Minggang WANG, Dewen. MAO. Mechanism of action of bile acid-farnesoid X receptor-intestinal microecological axis in the development of liver failure and liver regeneration[J]. Journal of Clinical Hepatology, 2021, 37(2): 480-484. doi: 10.3969/j.issn.1001-5256.2021.02.049
[16]	Menghao LI, Kai LI, Shihao TANG, Zhengyu WANG, Wengang GUO, Zhanxin YIN, Guohong HAN. Changes in gut microbiota after transjugular intrahepatic portosystemic shunt in cirrhotic patients with mild hepatic encephalopathy in different prognosis groups[J]. Journal of Clinical Hepatology, 2021, 37(2): 326-330. doi: 10.3969/j.issn.1001-5256.2021.02.016
[17]	Li HongShan, Hu YiYang. Gut microecology: An important target of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(1): 14-18. doi: 10.3969/j.issn.1001-5256.2020.01.002
[18]	Huang YunYi, Liu Yao, Zhang Qun, Shi Ke, Wang XianBo. Association of intestinal microecology with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2020, 36(4): 912-914. doi: 10.3969/j.issn.1001-5256.2020.04.045
[19]	Huang Qian, Zhang HaiBo, Li JingTao, Wei HaiLiang, Yan ShuGuang, Hui Yi, Chang ZhanJie. Research advances in the mechanism of action of intestinal microecology in intrahepatic cholestasis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2355-2359. doi: 10.3969/j.issn.1001-5256.2019.10.050
[20]	Zheng Wei, Zhang YongHong, Zhao Yan. Role of intestinal microflora in the pathogenesis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(7): 1613-1615. doi: 10.3969/j.issn.1001-5256.2019.07.041

Supplements(0)

Cited By

Cited by

Periodical cited type(9)

1.	刘韦，白浪. 慢加急性肝衰竭动物模型研究现状. 临床肝胆病杂志. 2024(01): 187-192 . 本站查看
2.	陈然，王帅，高扬，杨志琴，徐严. HBV相关慢加急性肝衰竭合并脓毒症的诊疗进展. 肝脏. 2024(07): 867-870 .
3.	刘扬，洪文，黄克林，杨博，刘亚坡，路明. 粪菌移植对顽固性便秘小鼠的肠道菌群和肠道动力以及TLR4/NF-κB通路蛋白的影响. 现代生物医学进展. 2024(16): 3020-3024 .
4.	于丹丹，刘亚坡，洪文，杨博，张媛. 粪菌移植对顽固性便秘患者肠道功能、免疫功能及炎症反应的改善效果. 结直肠肛门外科. 2024(05): 578-583 .
5.	阮浩龙，王宁，于鸿浩，岳鹏鹏. 基于基因编辑技术研究特定基因对小鼠肠道微生物的影响. 中国医学工程. 2024(11): 44-49 .
6.	徐洪凯，汪春付，张野，连建奇. 粪菌移植在慢性肝病治疗中的应用. 临床肝胆病杂志. 2023(09): 2237-2243 . 本站查看
7.	周荃，蔡春琳，李金强. 肠-肝轴：肠道微生物稳态与肝细胞癌. 临床肝胆病杂志. 2023(11): 2710-2717 . 本站查看
8.	周宜，刘晓琴，吴学敏，张浩，王海琴，王红亮，孟祥龙. 乳香及其炮制品对葡聚糖硫酸钠诱导小鼠炎症性肠病的保护作用. 现代药物与临床. 2022(07): 1432-1438 .
9.	刘蕾，高越颖，郭琳，邱立朋，李会，耿燕. 酒精性肝损伤保护的药理实验教学设计. 实验室研究与探索. 2022(05): 238-243 .

Other cited types(2)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (778) PDF downloads(68)

Research advances in the molecular mechanism of long non-coding RNA in invasion and metastasis of pancreatic cancer

DOI: 10.3969/j.issn.1001-5256.2022.01.043